OrphanDC
https://www.orphandc.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From OrphanDC
Deal Watch: Amgen Taps Plexium's Expertise In Targeted Protein Degradation
Mersana will help J&J develop antibody-drug conjugates against three targets, while AstraZeneca out-licenses a candidate for peripheral artery disease to Regio.
Company Information
- Industry
- Contract Research Organization-CRO
- Research, Analytical Equipment & Supplies
- Services
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice